Sana Biotechnology appoints Brian Piper as CFO
Sana Biotechnology appointed Brian Piper as EVP and CFO to oversee finance as its clinical-stage cell and gene therapy programs advance.
Why it mattersBrian Piper's public-market CFO experience should tighten fundraising timing for Sana's clinical-stage cell and gene therapies.